1. Home
  2. SFBC vs CGTX Comparison

SFBC vs CGTX Comparison

Compare SFBC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sound Financial Bancorp Inc.

SFBC

Sound Financial Bancorp Inc.

HOLD

Current Price

$45.30

Market Cap

103.8M

Sector

Finance

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFBC
CGTX
Founded
1953
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.8M
102.9M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SFBC
CGTX
Price
$45.30
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
8.8K
1.1M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
2.04%
N/A
EPS Growth
53.89
62.79
EPS
0.61
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$75.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.68
$0.55
52 Week High
$48.85
$3.83

Technical Indicators

Market Signals
Indicator
SFBC
CGTX
Relative Strength Index (RSI) 47.27 37.20
Support Level $43.81 $0.55
Resistance Level $44.93 $1.19
Average True Range (ATR) 1.57 0.07
MACD -0.24 -0.00
Stochastic Oscillator 22.09 9.38

Price Performance

Historical Comparison
SFBC
CGTX

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: